Quote:

---

But now, Merck is laying the groundwork for his exit, as well as that of its seasoned research and development leader Roger Perlmutter, who is 66. At the same time, sales of Keytruda are beginning to mature, leading some investors to ask where the drug giant’s future growth will come from.

---